Invenomic Capital Management’s State Street STT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-40,641
Closed -$5.24M 179
2025
Q4
$5.24M Sell
40,641
-58,045
-59% -$6.95M 0.24% 109
2025
Q3
$11.4M Sell
98,686
-5,274
-5% -$589K 0.55% 65
2025
Q2
$11.1M Buy
103,960
+22,511
+28% +$2.08M 0.63% 60
2025
Q1
$7.29M Sell
81,449
-115,936
-59% -$11.1M 0.37% 90
2024
Q4
$19.4M Sell
197,385
-79,206
-29% -$7.5M 0.92% 29
2024
Q3
$24.5M Buy
276,591
+43,221
+19% +$3.56M 1.34% 21
2024
Q2
$17.3M Buy
233,370
+102,189
+78% +$7.62M 0.84% 43
2024
Q1
$10.1M Buy
+131,181
New +$9.73M 0.54% 65

Other funds holding STT

Invenomic Capital Management's STT Position: Q1 2026 in Review

Invenomic Capital Management sold out of State Street (STT) in Q1 2026, closing a stake of 40,641 shares — an estimated $5.24M sold.

Invenomic Capital Management first reported a position in STT in Q1 2024 and held it in 8 quarters. The position peaked at $24.5M in Q3 2024. 1,140 funds tracked by Wall St. Rank hold STT as of Q1 2026.

  • Invenomic Capital Management reported no remaining State Street position as of Q1 2026 after selling out during the quarter.
  • Invenomic Capital Management sold 40,641 State Street shares in Q1 2026, an estimated $5.24M.
  • Invenomic Capital Management first reported a position in State Street in Q1 2024 and held it in 8 quarters.
  • Invenomic Capital Management's State Street position peaked at $24.5M in Q3 2024.
  • 1,140 funds tracked by Wall St. Rank held State Street as of Q1 2026.

Based on Invenomic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.